Bevacizumab/temozolomideLack of efficacy: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1940卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31972-y

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：114 / 114

相关论文

共 50 条

[21] Bevacizumab/temozolomideLack of efficacy and hypermutation
Reactions Weekly, 2024, 2009 (1) : 115 - 115
[22] Bevacizumab/temozolomideLack of efficacy and various toxicities following off-label use: 2 case reports
Reactions Weekly, 2021, 1849 (1) : 93 - 93
[23] Bevacizumab/Irinotecan/TemozolomideLack of efficacy and veinous thromboembolic events: case report
Reactions Weekly, 2025, 2040 (1) : 180 - 180
[24] TemozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1940 (1) : 388 - 388
[25] TemozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1934 (1) : 394 - 394
[26] TemozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1931 (1) : 537 - 537
[27] TemozolomideLack of efficacy: case report
Reactions Weekly, 2025, 2049 (1) : 336 - 336
[28] TemozolomideLack of efficacy: case report
Reactions Weekly, 2025, 2043 (1) : 367 - 367
[29] Bevacizumab/fluorouracil/temozolomideVarious toxicities and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1952 (1) : 104 - 104
[30] TemozolomideLack of efficacy: case report
Reactions Weekly, 2021, 1873 (1) : 228 - 228

← 1 2 3 4 5 →